News & Articles

Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing

The assay has the ability to sequence and surveil evolution of virus mutations over time and geography

Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test

Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall

Protein Metrics’ software solutions complement Thermo Fisher’s mass spectrometry systems to facilitate precise, reliable data processing and drive innovation

Watch this on-demand webinar to discover mass spec solutions from Waters and expert insights to help optimize your methods

A novel machine learning method called DeepBAR could accelerate drug discovery and protein engineering

The monthly safety report will be made public on the European Medicines Agency website

The heart has a ‘natural backup pacemaker’ that can kick into action if the primary way the organ generates electrical signals fails

The test helps save on much-needed testing supplies since it allows for testing for all four viruses with one swab

New technology provides Waters’ Empower Chromatography Data System users with the ability to share and analyze lab instrument data

SARS-CoV-2 testing is a powerful tool for curbing the COVID-19 pandemic and safely reopening schools and businesses

The license from ERS expands ZeClinics CRISPR IP portfolio and increases the validity and potency of zebrafish models for the drug discovery process

Neuroscientists can now screen over 3,000 neurons from a NeuroHTS microplate in under 30 minutes with the ImageXpress Pico Automated Cell Imaging System

Emergency Use Listing granted to AstraZeneca and Serum Institute of India enabling global access to the vaccine

Focusing on innate immunity opens way for precision medicine approaches to AD

Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR

Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection

New partnership broadens access to oncology treatments across Latin America, Asia, Africa and the Western Pacific

Partnership aims to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing

The test could be used to assess antibody response against the native spike protein of SARS-CoV-2 following COVID-19 vaccination